1-12 of 12
Pierre J Lefèbvre
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Different Patterns of Insulin Resistance in Relatives of Type 1 Diabetic Patients With Retinopathy or Nephropathy : The Genesis France-Belgium Study

Samy Hadjadj, MD, PHD, Franck Péan, PHD, Yves Gallois, PHD, Philippe Passa, MD, Robert Aubert, PHD, Laurent Weekers, MD, Vincent Rigalleau, MD, PHD, Bernard Bauduceau, MD, Amine Bekherraz, MD, Ronan Roussel, MD, PHD, Bernard Dussol, MD, Michel Rodier, MD, Richard Marechaud, MD, Pierre J. Lefebvre, MD, PHD, Michel Marre, MD, PHD, for the Genesis France-Belgium Study
Journal: Diabetes Care
Diabetes Care 2004;27(11):2661–2668
https://doi.org/10.2337/diacare.27.11.2661
Published: 01 November 2004
View article titled, Different Patterns of Insulin Resistance in Relatives of Type 1 Diabetic Patients With Retinopathy or Nephropathy : <subtitle>The Genesis France-Belgium Study</subtitle>
Open the PDF for Different Patterns of Insulin Resistance in Relatives of Type 1 Diabetic Patients With Retinopathy or Nephropathy : <subtitle>The Genesis France-Belgium Study</subtitle> in another window
Journal Articles

Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control

LiYing Zhang, MSC, Georges Krzentowski, MD, Adelin Albert, PHD, Pierre J. Lefebvre, MD, PHD, FRCP
Journal: Diabetes Care
Diabetes Care 2001;24(7):1275–1279
https://doi.org/10.2337/diacare.24.7.1275
Published: 01 July 2001
View article titled, Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control
Open the PDF for Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control in another window
Journal Articles

Glucagon and its Family Revisited

Pierre J Lefèbvre, MD, PHD, FRCP
Journal: Diabetes Care
Diabetes Care 1995;18(5):715–730
https://doi.org/10.2337/diacare.18.5.715
Published: 01 May 1995
View article titled, Glucagon and its Family Revisited
Open the PDF for Glucagon and its Family Revisited in another window
Journal Articles

Detection of Early Sympathetic Cardiovascular Neuropathy by Squatting Test in NIDDM

Raffaele Marfella, MD, Teresa Salvatore, MD, Dario Glugliano, MD, Giosue Di Maro, MD, Riccardo Giunta, MD, Roberto Torella, MD, Jacques Juchmes, MD, Andre Scheen, MD, Pierre J Lefebvre, MD
Journal: Diabetes Care
Diabetes Care 1994;17(2):149–151
https://doi.org/10.2337/diacare.17.2.149
Published: 01 February 1994
View article titled, Detection of Early Sympathetic Cardiovascular Neuropathy by Squatting Test in NIDDM
Open the PDF for Detection of Early Sympathetic Cardiovascular Neuropathy by Squatting Test in NIDDM in another window
Journal Articles

Improvement of Insulin-Induced Glucose Disposal in Obese Patients With NIDDM After 1-Wk Treatment With d-Fenfluramine

André J Scheen, MD, Giuseppe Paolisso, MD, Teresa Salvatore, MD, Pierre J Lefèbvre, MD, PhD
Journal: Diabetes Care
Diabetes Care 1991;14(4):325–332
https://doi.org/10.2337/diacare.14.4.325
Published: 01 April 1991
View article titled, Improvement of Insulin-Induced Glucose Disposal in Obese Patients With NIDDM After 1-Wk Treatment With <em>d</em>-Fenfluramine
Open the PDF for Improvement of Insulin-Induced Glucose Disposal in Obese Patients With NIDDM After 1-Wk Treatment With <em>d</em>-Fenfluramine in another window
Journal Articles

Vitamin E Reduction of Protein Glycosylation in Diabetes: New Prospect for Prevention of Diabetic Complications?

Antonio Ceriello, MD, Dario Giugliano, MD, Antonio Quatraro, MD, Claudio Donzella, MD, Giovanni Dipalo, MD, Pierre J Lefebvre, MD
Journal: Diabetes Care
Diabetes Care 1991;14(1):68–72
https://doi.org/10.2337/diacare.14.1.68
Published: 01 January 1991
View article titled, Vitamin E Reduction of Protein Glycosylation in Diabetes: New Prospect for Prevention of Diabetic Complications?
Open the PDF for Vitamin E Reduction of Protein Glycosylation in Diabetes: New Prospect for Prevention of Diabetic Complications? in another window
Journal Articles

Decreased or Increased Insulin Metabolism After Glipizide in Type II Diabetes?

André J Scheen, MD, Manuel J Castillo, MD, Pierre J Lefèbvre, MD, PhD
Journal: Diabetes Care
Diabetes Care 1988;11(8):687–689
https://doi.org/10.2337/diacare.11.8.687c
Published: 01 September 1988
View article titled, Decreased or Increased Insulin Metabolism After Glipizide in Type II Diabetes?
Open the PDF for Decreased or Increased Insulin Metabolism After Glipizide in Type II Diabetes? in another window
Journal Articles

Statement on Postprandial Hypoglycemia

Pierre J Lefèbvre, MD, Domenico Andreani, MD, Vincent Marks, MD, Werner Creutzfeldt, MD
Journal: Diabetes Care
Diabetes Care 1988;11(5):439–440
https://doi.org/10.2337/diacare.11.5.439b
Published: 01 May 1988
View article titled, Statement on Postprandial Hypoglycemia
Open the PDF for Statement on Postprandial Hypoglycemia in another window
Journal Articles

U-100 Insulin Gives Some Protection Against Metabolic Deterioration Due to CSII Interruption

André J Scheen, MD, Philippe Henrivaux, MD, Bernard Jandrain, MD, Pierre J Lefébvre, MD, PhD
Journal: Diabetes Care
Diabetes Care 1987;10(6):707–711
https://doi.org/10.2337/diacare.10.6.707
Published: 01 November 1987
View article titled, U-100 Insulin Gives Some Protection Against Metabolic Deterioration Due to CSII Interruption
Open the PDF for U-100 Insulin Gives Some Protection Against Metabolic Deterioration Due to CSII Interruption in another window
Journal Articles

Prevention of Metabolic Alterations by Insulin Supplements Administered Either Before or After 2-h Nocturnal Interruption of CSII

André J Scheen, MD, Philippe Henrivaux, MD, Bernard Jandrain, MD, Giuseppe Paolisso, MD, Pierre J Lefèbvre, MD, PhD
Journal: Diabetes Care
Diabetes Care 1987;10(5):567–572
https://doi.org/10.2337/diacare.10.5.567
Published: 01 September 1987
View article titled, Prevention of Metabolic Alterations by Insulin Supplements Administered Either Before or After 2-h Nocturnal Interruption of CSII
Open the PDF for Prevention of Metabolic Alterations by Insulin Supplements Administered Either Before or After 2-h Nocturnal Interruption of CSII in another window
Journal Articles

Lack of Systematic Metabolic Alterations After a One-hour Interruption of Continuous Subcutaneous Insulin Infusion in Type I Diabetic Patients

André Scheen, M.D., Philippe Henrivaux, M.D., Bernard Jandrain, M.D., Alfred S Luyckx, M.D., Ph.D., Pierre J Lefebvre, M.D., Ph.D.
Journal: Diabetes Care
Diabetes Care 1985;8(6):621–623
https://doi.org/10.2337/diacare.8.6.621
Published: 01 November 1985
View article titled, Lack of Systematic Metabolic Alterations After a One-hour Interruption of Continuous Subcutaneous Insulin Infusion in Type I Diabetic Patients
Open the PDF for Lack of Systematic Metabolic Alterations After a One-hour Interruption of Continuous Subcutaneous Insulin Infusion in Type I Diabetic Patients in another window
Journal Articles

Metabolic Alterations After a Two-hour Nocturnal Interruption of a Continuous Subcutaneous Insulin Infusion

André Scheen, M.D., Manuel Castillo, M.D., Bernard Jandrain, M.D., Georges Krzentowski, M.D., Philippe Henrivaux, M.D., Alfred S Luyckx, M.D. Ph.D., Pierre J Lefèbvre, M.D. Ph.D.
Journal: Diabetes Care
Diabetes Care 1984;7(4):338–342
https://doi.org/10.2337/diacare.7.4.338
Published: 01 July 1984
View article titled, Metabolic Alterations After a Two-hour Nocturnal Interruption of a Continuous Subcutaneous Insulin Infusion
Open the PDF for Metabolic Alterations After a Two-hour Nocturnal Interruption of a Continuous Subcutaneous Insulin Infusion in another window